Differential effects of sulfonylurea derivatives on vascular ATP-sensitive potassium channels

European Journal of Pharmacology

Volumn 681, Issue 1-3, 2012, Pages 75-79

  Engbersen, Richard ^a   Masereeuw, Rosalinde ^a   Van Gestel, Miriam A ^a   Siero, Helene L M ^a   Moons, Miek M ^a   Smits, Paul ^a   Russel, Frans G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ATP sensitive potassium channel; Isolated perfused kidney; Sulfonylurea drug; Vascular smooth muscle

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLIBENCLAMIDE; GLICLAZIDE; GLIMEPIRIDE; GLIPIZIDE; PINACIDIL; SULFONYLUREA DERIVATIVE;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; CARDIOVASCULAR RISK; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BINDING; DRUG EFFECT; DRUG MECHANISM; EX VIVO STUDY; MALE; MESENTERIC ARTERY; MYOGRAPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; RENAL ARTERY; SHIFT TO THE RIGHT; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; KATP CHANNELS; KIDNEY; MALE; MESENTERIC ARTERIES; MUSCLE, SMOOTH, VASCULAR; PHENYLEPHRINE; RATS; RATS, INBRED WKY; RENAL ARTERY; SULFONYLUREA COMPOUNDS; VASOCONSTRICTION; VASODILATION;

EID: 84858707240     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.02.006     Document Type: Article

References (39)

1. E.J. Abbink, P. Pickkers, v.R. Jansen, J.A. Lutterman, C.J. Tack, F.G. Russel, and P. Smits Vascular effects of glibenclamide vs. glimepiride and metformin in Type 2 diabetic patients Diabet. Med. 19 2002 136 143 (Pubitemid 34225228)
2. F.M. Ashcroft ATP-sensitive potassium channelopathies: focus on insulin secretion J. Clin. Invest. 115 2005 2047 2058 (Pubitemid 41134141)
3. F.M. Ashcroft, and F.M. Gribble Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels J. Diabetes Complications 14 2000 192 196
4. R. Ashfield, F.M. Gribble, S.J. Ashcroft, and F.M. Ashcroft Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel Diabetes 48 1999 1341 1347 (Pubitemid 29241036)
5. T. Aversano, P. Ouyang, and H. Silverman Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation Circ. Res. 69 1991 618 622
6. P.J. Bijlstra, J.A. den Arend, J.A. Lutterman, F.G. Russel, T. Thien, and P. Smits Blockade of vascular ATP-sensitive potassium channels reduces the vasodilator response to ischaemia in humans Diabetologia 39 1996 1562 1568 (Pubitemid 26397368)
7. P.J. Bijlstra, J.A. Lutterman, F.G. Russel, T. Thien, and P. Smits Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans [published erratum appears in Diabetologia 1996 Nov;39(11):1414] Diabetologia 39 1996 1083 1090 (Pubitemid 26275939)
8. W.C. Cole, C.D. McPherson, and D. Sontag ATP-regulated K + channels protect the myocardium against ischemia/reperfusion damage Circ. Res. 69 1991 571 581
9. F.Z. Cyrino, D.A. Bottino, F.C. Coelho, D. Ravel, and E. Bouskela Effects of sulfonylureas on K(ATP) channel-dependent vasodilation J. Diabetes Complications 17 2003 6 10 (Pubitemid 36293502)
10. J. Daut, W. Maier-Rudolph, N. von Beckerath, G. Mehrke, K. Gunther, and L. Goedel-Meinen Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels Science 247 1990 1341 1344
11. T.M. Davis, F. Daly, J.P. Walsh, K.F. Ilett, J.P. Beilby, L.J. Dusci, and P.H. Barrett Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes Br. J. Clin. Pharmacol. 49 2000 223 230 (Pubitemid 30150983)
12. P. Dhindsa, K.R. Davis, and R. Donnelly Comparison of the micro- and macro-vascular effects of glimepiride and gliclazide in metformin-treated patients with Type 2 diabetes: a double-blind, crossover study Br. J. Clin. Pharmacol. 55 2003 616 619 (Pubitemid 36783205)
13. M. Eltze, B. Ullrich, E. Mutschler, U. Moser, E. Bungardt, T. Friebe, C. Gubitz, R. Tacke, and G. Lambrecht Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney Eur. J. Pharmacol. 238 1993 343 355 (Pubitemid 23214450)
14. R. Engbersen, M.M. Moons, A.C. Wouterse, H.B. Dijkman, C. Kramers, P. Smits, and F.G. Russel Sulphonylurea drugs reduce hypoxic damage in the isolated perfused rat kidney Br. J. Pharmacol. 130 2000 1678 1684 (Pubitemid 30611948)
15. H.M. Farouque, S.G. Worthley, I.T. Meredith, R.A. Skyrme-Jones, and M.J. Zhang Effect of ATP-sensitive potassium channel inhibition on resting coronary vascular responses in humans Circ. Res. 90 2002 231 236 (Pubitemid 34627093)
16. T.P. Flagg, D. Enkvetchakul, J.C. Koster, and C.G. Nichols Muscle KATP channels: recent insights to energy sensing and myoprotection Physiol. Rev. 90 2010 799 829
17. K. Geisen, A. Vegh, E. Krause, and J.G. Papp Cardiovascular effects of conventional sulfonylureas and glimepiride Horm. Metab. Res. 28 1996 496 507 (Pubitemid 26343742)
18. L. Gojkovic, and T. Kazic A comparison of the relaxant effects of pinacidil in rabbit renal and mesenteric artery Gen. Pharmacol. 25 1994 1711 1717
19. F.M. Gribble, and F. Reimann Sulphonylurea action revisited: the post-cloning era Diabetologia 46 2003 875 891 (Pubitemid 36961311)
20. G.J. Gross, and J.A. Auchampach Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs Circ. Res. 70 1992 223 233
21. S.M. Haffner Coronary heart disease in patients with diabetes N. Engl. J. Med. 342 2000 1040 1042 (Pubitemid 30180652)
22. S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N. Engl. J. Med. 339 1998 229 234 (Pubitemid 28350165)
23. D. Janigro, G.A. West, E.L. Gordon, and H.R. Winn ATP-sensitive K + channels in rat aorta and brain microvascular endothelial cells Am. J. Physiol. 265 1993 C812 C821
24. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1998 1414 1431 (Pubitemid 28405191)
25. G. Leibowitz, and E. Cerasi Sulphonylurea treatment of NIDDM patients with cardiovascular disease: a mixed blessing? Diabetologia 39 1996 503 514 (Pubitemid 26135453)
26. R. Masereeuw, S. Notenboom, P.H. Smeets, A.C. Wouterse, and F.G. Russel Impaired renal secretion of substrates for the multidrug resistance protein 2 in mutant transport-deficient (TR-) rats J. Am. Soc. Nephrol. 14 2003 2741 2749 (Pubitemid 37305636)
27. D.K. McGuire, L.K. Newby, M.V. Bhapkar, D.J. Moliterno, J.S. Hochman, W.W. Klein, W.D. Weaver, M. Pfisterer, R. Corbalan, M. Dellborg, C.B. Granger, F. Van De Werf, E.J. Topol, and R.M. Califf Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes Am. Heart J. 147 2004 246 252 (Pubitemid 38176824)
28. A. Melander Kinetics-effect relations of insulin-releasing drugs in patients with type 2 diabetes: brief overview Diabetes 53 Suppl. 3 2004 S151 S155
29. M.J. Mulvany, and W. Halpern Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats Circ. Res. 41 1977 19 26 (Pubitemid 8132079)
30. U. Quast, D. Stephan, S. Bieger, and U. Russ The impact of ATP-sensitive K + channel subtype selectivity of insulin secretagogues for the coronary vasculature and the myocardium Diabetes 53 Suppl. 3 2004 S156 S164
31. D. Ravel, N. Levens, M. Feletou, G. Neliat, J. Auclair, and E. Bouskela Differential effects of sulphonylureas on the vasodilatory response evoked by K(ATP) channel openers Fundam. Clin. Pharmacol. 17 2003 61 69 (Pubitemid 36241454)
32. S.M. Sadikot, and C.E. Mogensen Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case-control study Diabetes Res. Clin. Pract. 82 2008 391 395
33. T.K. Schramm, G.H. Gislason, A. Vaag, J.N. Rasmussen, F. Folke, M.L. Hansen, E.L. Fosbol, L. Kober, M.L. Norgaard, M. Madsen, P.R. Hansen, and C. Torp-Pedersen Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study Eur. Heart J. 32 2011 1900 1908
34. P. Smits, and T. Thien Cardiovascular effects of sulphonylurea derivatives. Implications for the treatment of NIDDM? Diabetologia 38 1995 116 121
35. D.K. Song, and F.M. Ashcroft Glimepiride block of cloned beta-cell, cardiac and smooth muscle K(ATP) channels Br. J. Pharmacol. 133 2001 193 199 (Pubitemid 32500467)
36. M. Suzuki, R.A. Li, T. Miki, H. Uemura, N. Sakamoto, Y. Ohmoto-Sekine, M. Tamagawa, T. Ogura, S. Seino, E. Marban, and H. Nakaya Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice Circ. Res. 88 2001 570 577 (Pubitemid 32275792)
37. J.D. Thornton, C.S. Thornton, D.L. Sterling, and J.M. Downey Blockade of ATP-sensitive potassium channels increases infarct size but does not prevent preconditioning in rabbit hearts Circ. Res. 72 1993 44 49
38. M. Yamada, S. Isomoto, S. Matsumoto, C. Kondo, T. Shindo, Y. Horio, and Y. Kurachi Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea-sensitive but ATP-insensitive K + channel J. Physiol. Lond. 499 1997 715 720 (Pubitemid 27153593)
39. H. Yoshida, J.E. Feig, A. Morrissey, I.A. Ghiu, M. Artman, and W.A. Coetzee K ATP channels of primary human coronary artery endothelial cells consist of a heteromultimeric complex of Kir6.1, Kir6.2, and SUR2B subunits J. Mol. Cell. Cardiol. 37 2004 857 869 (Pubitemid 39232076)